TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.

Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 healthcare AI stocks to buy according to hedge funds. On June 30, 2025, ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 10 Stocks Crash Hard on a Roaring Monday. Tempus AI dropped for a second day on ...

Tempus AI, Inc. ("Tempus") (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s ...

Tempus AI's innovation in genomics, data, and applications makes the company well positioned to become a contender in the AI ...

Tempus AI (NasdaqGS:TEM) recently saw its market presence elevated as it was added to multiple Russell indices, showcasing an enhanced visibility. The company also bolstered its strategic partnerships ...

Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which ...

Tempus AI TEM and Guardant Health GH are two dominant players in the field of AI-powered precision oncology. Tempus, newly ...

Analysts have recently evaluated Tempus AI and provided 12-month price targets. The average target is $67.88, accompanied by a high estimate of $70.00 and a low estimate of $60.00. Observing a 7.75% ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM) common stock ...